Marc Benioff — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)
Co-investorsAIX VenturesBreakout VenturesGaingelsHumba VenturesImmeasurableJulian Capital+19 more
Sumble provides GTM teams with a structured view of target accounts, mapping teams, reporting lines, technologies in use, hiring activity, and buying signals so reps can identify decision-makers and personalize outreach.
Data & InfrastructureSaaSSales TechSan Francisco, US
Anthony Goldbloom(Founder)inBen Hamner(Founder)in
Co-investorsAIX VenturesBloomberg BetaCoatue ManagementOctaveSquare Peg CapitalVery Serious Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)
.jpeg)





